Internal medicine, Surgery, Gastroenterology, Vasculitis and Randomized controlled trial are his primary areas of study. His work in Microscopic polyangiitis, Azathioprine, Adverse effect, Granulomatosis with polyangiitis and Survival rate are all subfields of Internal medicine research. In his study, Cohort and Methotrexate is inextricably linked to Rheumatology, which falls within the broad field of Surgery.
Xavier Puéchal combines subjects such as Multicenter trial, Infliximab, Immunology, Pathology and Whipple Disease with his study of Gastroenterology. The various areas that Xavier Puéchal examines in his Vasculitis study include Systemic disease and Arthritis. His work deals with themes such as Placebo and Clinical trial, which intersect with Randomized controlled trial.
His primary areas of investigation include Internal medicine, Gastroenterology, Vasculitis, Granulomatosis with polyangiitis and Surgery. His study in Microscopic polyangiitis, Rituximab, Randomized controlled trial, Rheumatoid arthritis and Rheumatology is carried out as part of his Internal medicine studies. His Gastroenterology research integrates issues from Prospective cohort study, Azathioprine, ANCA-Associated Vasculitis and Cohort.
His work carried out in the field of Vasculitis brings together such families of science as Dermatology and Immunology. The Granulomatosis with polyangiitis study combines topics in areas such as Asthma, Retrospective cohort study and Eosinophilic. His research on Surgery often connects related areas such as Adverse effect.
His main research concerns Internal medicine, Vasculitis, Granulomatosis with polyangiitis, Gastroenterology and Rituximab. Internal medicine and In patient are two areas of study in which Xavier Puéchal engages in interdisciplinary work. His Vasculitis research includes themes of Clinical endpoint and Cohort.
His Granulomatosis with polyangiitis research is multidisciplinary, relying on both Microscopic polyangiitis, Prednisone, Eosinophilic and Asthma. His Gastroenterology research focuses on subjects like Kidney, which are linked to Pathology. In his research, Lung, Plasmapheresis, Methylprednisolone, Glomerulonephritis and Proteinase 3 is intimately related to Azathioprine, which falls under the overarching field of Rituximab.
Xavier Puéchal mostly deals with Internal medicine, Granulomatosis with polyangiitis, Rituximab, Vasculitis and Maintenance therapy. His Internal medicine study focuses on Randomized controlled trial in particular. His Granulomatosis with polyangiitis study combines topics in areas such as Eye disease, Concomitant, Autoimmunity and Retrospective cohort study.
He works mostly in the field of Rituximab, limiting it down to concerns involving Adverse effect and, occasionally, Prednisone, Proportional hazards model and Refractory. His Vasculitis research incorporates elements of Interquartile range, Asthma and Single Center. Maintenance therapy is connected with Microscopic polyangiitis, Gastroenterology and Anti-neutrophil cytoplasmic antibody in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
Loïc Guillevin;Christian Pagnoux;Alexandre Karras;Chahera Khouatra.
The New England Journal of Medicine (2014)
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Régis Sablé-Fourtassou;Pascal Cohen;Alfred Mahr;Christian Pagnoux.
Annals of Internal Medicine (2005)
Florence Fenollar;Xavier Puéchal;Didier Raoult.
The New England Journal of Medicine (2007)
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
Cloé Comarmond;Christian Pagnoux;Mehdi Khellaf;Jean-François Cordier.
Arthritis & Rheumatism (2013)
Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Christian Pagnoux;Alfred Mahr;Mohamed A. Hamidou;Jean-Jacques Boffa.
The New England Journal of Medicine (2008)
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.
Gary S. Hoffman;Maria C. Cid;David B. Hellmann;Loic Guillevin.
Arthritis & Rheumatism (2002)
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron.
Arthritis & Rheumatism (2004)
Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial
Valérie Devauchelle-Pensec;Xavier Mariette;Sandrine Jousse-Joulin;Jean-Marie Berthelot.
Annals of Internal Medicine (2014)
Vasculitides associated with malignancies: analysis of sixty patients.
Olivier Fain;Mohamed Hamidou;Patrice Cacoub;Bertrand Godeau.
Arthritis & Rheumatism (2007)
Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
Camillo Ribi;Pascal Cohen;Christian Pagnoux;Alfred Mahr.
Arthritis & Rheumatism (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: